WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can infect several organs, especially impacting respiratory capacity. Among the extrapulmonary manifestations of COVID-19 is myocardial injury, which is associated with a high risk of...

詳細記述

書誌詳細

主要な著者:	Luiz Guilherme H. S. Aragão, Júlia T. Oliveira, Jairo R. Temerozo, Mayara A. Mendes, José Alexandre Salerno, Carolina S. G. Pedrosa, Teresa Puig-Pijuan, Carla P. Veríssimo, Isis M. Ornelas, Thayana Torquato, Gabriela Vitória, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Suelen da Silva Gomes Dias, Vinicius Cardoso Soares, Letícia R. Q. Souza, Karina Karmirian, Livia Goto-Silva, Diogo Biagi, Estela M. Cruvinel, Rafael Dariolli, Daniel R. Furtado, Patrícia T. Bozza, Helena L. Borges, Thiago M. L. Souza, Marília Zaluar P. Guimarães, Stevens K. Rehen
フォーマット:	Artigo
言語:	Inglês
出版事項:	PeerJ Inc. 2021-10-01
シリーズ:	PeerJ
主題:	Cannabinoids SARS-Cov-2 COVID-19 Human iPSC-derived cardiomyocytes WIN 55,212-2
オンライン･アクセス:	https://peerj.com/articles/12262.pdf
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!